<--- Back to Details
First PageDocument Content
Histone H3 / Histone deacetylase / Histone / MicroRNA / Ethanol / MiR-122 / Nucleosome / Genomic imprinting / Regulation of gene expression / Biology / Genetics / Epigenetics
Date: 2013-08-08 18:29:54
Histone H3
Histone deacetylase
Histone
MicroRNA
Ethanol
MiR-122
Nucleosome
Genomic imprinting
Regulation of gene expression
Biology
Genetics
Epigenetics

Alcohol Research: Current Reviews Volume 35

Add to Reading List

Source URL: pubs.niaaa.nih.gov

Download Document from Source Website

File Size: 423,17 KB

Share Document on Facebook

Similar Documents

Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis

Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis

DocID: 19W6r - View Document

Article in press - uncorrected proof Clin Chem Lab Med 2011;49(10):xxx-xxx  2011 by Walter de Gruyter • Berlin • Boston. DOICCLMReview  Prognostic, therapeutic and diagnostic potential of microRNA

Article in press - uncorrected proof Clin Chem Lab Med 2011;49(10):xxx-xxx  2011 by Walter de Gruyter • Berlin • Boston. DOICCLMReview Prognostic, therapeutic and diagnostic potential of microRNA

DocID: 19zws - View Document

Downloaded from rnajournal.cshlp.org on July 28, Published by Cold Spring Harbor Laboratory Press  Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell Georgia Sotiropoulo

Downloaded from rnajournal.cshlp.org on July 28, Published by Cold Spring Harbor Laboratory Press Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell Georgia Sotiropoulo

DocID: 199TC - View Document

MiR-27 / Mir-223 / Mir-31 / MiR-214 / Mir-48 / MiR-138 / MiR-296 / Mir-200 / Mir-22 / MicroRNA / Mir-126 / MiR-122

miRNAs in macrophages and adipocytes - Supplemental Tables Table S1 Most significant differences regarding miRNAs availability in macrophages (M1) and adipocytes (MAs) and into supernatants (SN) at the basal level and u

DocID: 175SZ - View Document

A Single Subcutaneous Dose of 2 mg/kg or 4 mg/kg of RG-101, a GalNAc-Conjugated Oligonucleotide with Antagonist Activity against miR-122, Results in Significant Viral Load Reductions in Chronic Hepatitis C  Patients

A Single Subcutaneous Dose of 2 mg/kg or 4 mg/kg of RG-101, a GalNAc-Conjugated Oligonucleotide with Antagonist Activity against miR-122, Results in Significant Viral Load Reductions in Chronic Hepatitis C Patients

DocID: 160Pd - View Document